Deuxiemeavis.fr

Deuxième Avis is a medical consulting company offering expert second opinions to patients, helping them make informed health decisions regarding complex medical issues. Deuxième Avis was founded in 2015 and is headquartered in Paris, France. The company provides expert medical second opinions to assist patients facing complex health issues. The founder's history and previous ventures are not disclosed.

In October 2018, Deuxième Avis raised EUR 2. 581 mn in a funding round led by Citizen Capital, Colam Entreprendre, and Investir&+, bringing the total amount raised to EUR 2. 581 mn and resulting in a current company valuation of EUR 5. 423 mn.

The company has completed a total of 3 deals. Deuxième Avis specializes in providing expert medical second opinions, aimed at assisting patients in making informed decisions regarding complex health issues. The company's core service allows patients to receive an evaluation of their medical case from a specialist in their specific health concern, ensuring the opinions are grounded in expertise and evidence-based guidelines. The service is designed to help patients navigate significant medical decisions, such as whether to undergo a major surgery or pursue alternative treatments, ultimately preventing unnecessary procedures and providing tailored treatment pathways.

The client base primarily includes individuals facing challenging health conditions, such as cancers, cardiovascular diseases, and neurological disorders. Deuxième Avis operates within various European markets, ensuring accessibility to its services for a broad demographic seeking reliable medical insights. Revenue for Deuxième Avis is generated through a direct-to-consumer model where patients pay for expert medical consultations. The company offers a streamlined process where clients submit their medical records and receive a specialist's opinion within a specified timeframe, typically seven days.

The transaction structure is primarily based on one-time consultations, where each second opinion request entails a comprehensive review by an accredited physician, ensuring a clear and transparent pricing model. While specific pricing details for services are not disclosed, the firm’s offerings are tailored to encompass a range of medical specialties, providing value to individuals seeking clarity on their health conditions. This approach positions Deuxième Avis as a pivotal resource in medical decision-making, facilitating informed choices for patients and enhancing their healthcare experiences. In the future, Deuxième Avis aims to expand its service offerings and enter new markets.

This includes upcoming products designed to enhance patient experience, although specific details and release dates have not been disclosed. The recent funding of EUR 2. 581 mn will support these initiatives, allowing the company to strengthen its market presence and improve service delivery. The expansion strategy includes targeting additional European markets by the end of 2023, further broadening its reach to patients seeking second opinions on medical conditions.